Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy

INTRODUCTION: Cancer Immunotherapy has recently emerged as a promising and effective modality to treat different malignancies. Antigenic profiling of cancer tissues and determination of any pre-existing immune responses to cancer antigens may help predict responses to immune intervention in cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Raza, Afsheen, Merhi, Maysaloun, Inchakalody, Varghese Philipose, Krishnankutty, Roopesh, Relecom, Allan, Uddin, Shahab, Dermime, Said
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102435/
https://www.ncbi.nlm.nih.gov/pubmed/32220256
http://dx.doi.org/10.1186/s12967-020-02306-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102435/
https://www.ncbi.nlm.nih.gov/pubmed/32220256
http://dx.doi.org/10.1186/s12967-020-02306-y

Ejemplares similares